FibroBiologics, Inc. Common Stock and Additional Paid-In Capital
FibroBiologics, Inc. (FBLG) had Common Stock and Additional Paid-In Capital of $10.00 million as of 2022-12-31, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2024-11-12
- 2022-12-31: Common Stocks, Including Additional Paid in Capital $10.00M.
| Period end | Common Stocks, Including Additional Paid in Capital |
|---|---|
| 2022-12-31 | $10.00M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |